CLINICAL ACCOUNT MANAGER
Openings available in Houston TX, Dallas TX, Chicago IL, New York/New England
​
SANUWAVE is a shockwave technology company developing patented, noninvasive devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. Its lead product, the dermaPACE System, is FDA Cleared for the treatment of Diabetic Foot Ulcers (DFU) in the United States.
​
For International Markets, the dermaPACE System is CE Marked for use on acute and chronic defects of the skin and subcutaneous soft tissue.
®
®
PACE TECHNOLOGY
®
Pulsed Acoustic Cellular Expression (PACE ) is SANUWAVE's proprietary form of Extracorporeal Shock Wave Therapy (ESWT). PACE utilizes high-energy acoustic pressure waves in the shock wave spectrum to produce compressive and tensile stresses on cells and tissue structures to elicit a series of biological responses.
®
®
PACE treatment results in an increase in perfusion and arteriogenesis, biofilm disruption, a pro-inflammatory response, cytokine and chemokine effects, growth factor upregulation, angiogenesis (new blood vessel formation) and the subsequent regeneration of tissue such as skin, musculoskeletal and vascular structures.
®
For in-depth discussion on the science behind shock waves, the difference between shock waves and ultrasound, how PACE technology differs from traditional shock wave therapy, as well as interviews and discussions with prominent Key Opinion Leaders (KOLs) in wound care, visit our BLOG.
®
